Tiziana Life Sciences Ltd (TLSA) Operating income 2016–2024
Tiziana Life Sciences Ltd (TLSA) annual operating income history from SEC filings — each fiscal year as reported.
-$15.8MFY2024 · since FY2016: -$9.9M → -$15.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$15.8M | +12.2% |
| FY2023 | -$18.0M | -23.3% |
| FY2022 | -$14.6M | +46.7% |
| FY2021 | -$27.4M | +2.3% |
| FY2020 | -$28.0M | -182.5% |
| FY2019 | -$9.9M | -0.5% |
| FY2018 | -$9.9M | +6.0% |
| FY2017 | -$10.5M | -6.2% |
| FY2016 | -$9.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSA financial trends
TLSA RevenueTLSA Net incomeTLSA Net marginTLSA Gross profitTLSA Gross marginTLSA Operating marginTLSA Operating cash flowTLSA Free cash flowTLSA Capital expendituresTLSA Return on equityTLSA Stock buybacksTLSA Dividends paidTLSA Total assetsTLSA Total liabilitiesTLSA Shareholders’ equityTLSA overview →